These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19570590)

  • 1. Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer.
    Funai K; Takamochi K; Itaya T; Mochizuki T; Nakamura T; Toyoda F; Yong-Il K; Sasaki K; Momiki S; Takahashi T; Neyatani H; Suzuki K
    Lung Cancer; 2010 Apr; 68(1):78-83. PubMed ID: 19570590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer.
    Yamaguchi M; Takeo S; Suemitsu R; Matsuzawa H
    Cancer Chemother Pharmacol; 2010 May; 66(1):107-12. PubMed ID: 19809815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
    Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
    Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase II trial of adjuvant chemotherapy with bi-weekly carboplatin plus paclitaxel versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer.
    Uramoto H; Nakanishi R; Nagashima A; Uchiyama A; Inoue M; Osaki T; Yoshimatsu T; Sakata H; Nakanishi K; Yasumoto K
    Anticancer Res; 2010 Nov; 30(11):4695-9. PubMed ID: 21115926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine combined with cisplatin as adjuvant chemotherapy for non-small cell lung cancer: A retrospective analysis.
    Ma D; Wang J; Hao X; Wang Y; Hu X; Xing P; Li J
    Thorac Cancer; 2017 Sep; 8(5):482-488. PubMed ID: 28745824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split-dose cisplatin and vinorelbine as adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Hirai F; Seto T; Shimokawa M; Inamasu E; Toyozawa R; Toyokawa G; Yoshida T; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
    Anticancer Res; 2014 Feb; 34(2):927-31. PubMed ID: 24511034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.
    Parra HS; Cavina R; Latteri F; Campagnoli E; Morenghi E; Torri W; Brambilla G; Alloisio M; Santoro A
    Invest New Drugs; 2007 Feb; 25(1):57-62. PubMed ID: 16699975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma.
    Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A
    Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective.
    Barlesi F; Chouaid C; Crequit J; Le Caer H; Pujol JL; Legodec J; Vergnenegre A; Le Treut J; Fabre-Guillevin E; Loundou A; Auquier P; Simeoni MC; Thomas PA
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):783-90. PubMed ID: 25765952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer.
    Karacetin D; Incekara O
    J BUON; 2006; 11(2):181-4. PubMed ID: 17318968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.
    Usami N; Yokoi K; Hasegawa Y; Taniguchi H; Shindo J; Yamamoto M; Suzuki R; Imaizumi K; Kondo M; Shimokata K;
    Int J Clin Oncol; 2010 Dec; 15(6):583-7. PubMed ID: 20714770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.
    Mylonakis N; Athanasiou A; Ziras N; Angel J; Rapti A; Lampaki S; Politis N; Karanikas C; Kosmas C
    Lung Cancer; 2010 May; 68(2):240-7. PubMed ID: 19628292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the safety and compliance of 3-week cycles of vinorelbine on days 1 and 8 and cisplatin on day 1 as adjuvant chemotherapy in Japanese patients with completely resected pathological stage IB to IIIA non-small cell lung cancer: a retrospective study.
    Shukuya T; Takahashi T; Tamiya A; Ono A; Igawa S; Tsuya A; Nakamura Y; Murakami H; Naito T; Kaira K; Endo M; Yamamoto N
    Jpn J Clin Oncol; 2009 Mar; 39(3):158-62. PubMed ID: 19139038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
    Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
    Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
    Huisman C; Giaccone G; van Groeningen CJ; Sutedja G; Postmus PE; Smit EF
    Lung Cancer; 2001; 33(2-3):267-75. PubMed ID: 11551422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and toxicity of adjuvant cisplatin and gemcitabine for treating non-small cell lung cancer.
    Yang F; Li X; Chen KZ; Jiang GC; Wang J
    Chin Med J (Engl); 2013; 126(11):2087-91. PubMed ID: 23769563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: a phase II study.
    Aydiner A; Kiyik M; Cikrikcioglu S; Kosar F; Gurses A; Turna A; Yazar A; Dilege S; Goksel T; Cakan A
    Lung Cancer; 2007 Nov; 58(2):246-52. PubMed ID: 17683827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.
    Soto Parra H; Cavina R; Latteri F; Sala A; Dambrosio M; Antonelli G; Morenghi E; Alloisio M; Ravasi G; Santoro A
    Ann Oncol; 2002 Jul; 13(7):1080-6. PubMed ID: 12176787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective phase II trial of a combination of fixed dose rate infusion of gemcitabine with cisplatin and UFT as a first-line treatment in patients with advanced non-small-cell lung carcinoma.
    Shin SJ; Kim H; Baek JH; Ahn JJ; Jegal Y; Seo KW; Park CR; Shin JK; Jung JP; Kim JW; Cha HJ; Kwon WJ; Jeong AK; Noh YJ; Park JH; Min YJ
    Lung Cancer; 2008 Apr; 60(1):83-91. PubMed ID: 18006180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
    Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
    J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.